Table 2 Relationship between the grading and immunostaining results.

From: Quantification of contrast agent uptake in the hepatobiliary phase helps to differentiate hepatocellular carcinoma grade

 

G1

G2

G3

Percentage of positive cells, n (%)

0%

3 (9.1)

8 (24.2)

5 (15.2)

1–10%

4 (12.1)

4 (12.1)

11–50%

5 (15.2)

2 (6.1)

51–80%

81–100%

2 (6.1)

Intensity of staining, n (%)

Absent

3 (9.1)

8 (24.2)

5 (15.2)

Weak

2 (6.1)

1 (3.0)

Moderate

4 (12.1)

4 (12.1)

Strong

5 (15.2)

1 (3.0)

Immunoreactive score, n (%)

Negative (0)

3 (9.1)

8 (24.2)

5 (15.2)

Low (1–3)

4 (12.1)

4 (12.1)

Medium (4–8)

5 (15.2)

2 (6.1)

High (9–12)

2 (6.1)